Tomopenem

N/A

Report date: 2022/05/18 16:21:08
NME

Base Information

Drug NameTomopenem
Drug Alias Name托莫培南CS-023R-1558RO-4908463R-115685
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionPeripheral benzodiazepine receptor binders
TargetsPeripheral benzodiazepine receptor
Therapy Area/IndicationsPneumoniaGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsPneumoniaGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG